MedPath

Detecting Fluid Accumulation With a Wearable Bioimpedance Sensor

Not Applicable
Recruiting
Conditions
Overhydration
Edema
Kidney Failure
Registration Number
NCT06053710
Lead Sponsor
Mode Sensors AS
Brief Summary

The investigation is a prospective cohort study, where two patient groups will be monitored by a wearable bioimpedance sensor during their scheduled treatment. The overall objective is to assess the bioimpedance sensor's ability to detect local and systemic fluid accumulation.

Sub-investigation A will investigate the ability of the device to detect fluid accumulation in patients with stable chronic kidney disease undergoing regular and planned hemodialysis.

Sub-investigation B will investigate the ability of the device to track hydration status in patients scheduled for an "intensive" dialysis treatment regime, due to severe overhydration.

Detailed Description

In Sub-investigation A, patients will be monitored for at least 10 consecutive dialysis sessions, and for a minimum of 3 weeks. Patients will wear two sensors (upper back and lower anterior leg).

In Sub-investigation B, patients will use the device throughout their whole treatment period, and for most patients, this will correspond to 2-6 dialysis treatments over 3 to 10 days. Patients will wear four patches (upper back, lateral thorax, anterior thigh, and lower anterior leg).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
24
Inclusion Criteria
  • Age ≥ 18 years
  • Regular hemodialysis (≥ 2 times weekly) with ultrafiltration volume ≥ 1 liter (Sub-investigation A)
  • Scheduled for intensive dialysis treatment due to severe overhydration (Sub-investigation B)
Exclusion Criteria
  • Known allergies or skin sensitivities to electrode hydrogel and/or acrylic adhesives
  • Implantable pulse generators such as pacemakers and defibrillators, and/or use of other electrical medical equipment for which an interaction effect with the investigational device cannot be ruled out.
  • Patients undergoing MRI
  • Breached skin at patch mounting area
  • Pregnancy
  • Any medical or psychiatric condition, which in the opinion of the investigator precludes participation

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
The effect of interdialytic fluid accumulation on the extracellular resistance of the upper back in stable chronic dialysis patients1-4 days

Relative change in extracellular resistance of the upper back, measured by the bioimpedance device in the interdialytic period in Sub-investigation A

Secondary Outcome Measures
NameTimeMethod
The effect of an intensive dialysis treatment regime on the extracellular resistance of the lower anterior leg in patients with severe overhydration2-10 days

Relative change in extracellular resistance of the lower anterior leg, measured by the bioimpedance device from before to after the dialysis treatment regime in Sub-investigation B

The effect of an intensive dialysis treatment regime on the extracellular resistance of the lateral thorax in patients with severe overhydration2-10 days

Relative change in extracellular resistance of the lateral thorax, measured by the bioimpedance device from before to after the dialysis treatment regime in Sub-investigation B

Safety of the investigational deviceUp to 4 weeks

Frequency and severity of adverse device effects.

The effect of interdialytic fluid accumulation on the extracellular resistance of the lower anterior leg in stable chronic dialysis patients1-4 days

Relative change in extracellular resistance of the lower anterior leg, measured by the bioimpedance device in the interdialytic period in Sub-investigation A

The effect of an intensive dialysis treatment regime on the extracellular resistance of the upper back in patients with severe overhydration2-10 days

Relative change in extracellular resistance of the upper back, measured by the bioimpedance device from before to after the dialysis treatment regime in Sub-investigation B

The effect of an intensive dialysis treatment regime on the extracellular resistance of the anterior thigh2-10 days

Relative change in extracellular resistance of the anterior thigh, measured by the bioimpedance device

Trial Locations

Locations (2)

Rikshospitalet, Oslo University Hospital

🇳🇴

Oslo, Norway

Ullevål sykehus, Oslo University Hospital

🇳🇴

Oslo, Norway

Rikshospitalet, Oslo University Hospital
🇳🇴Oslo, Norway
Hege K Pihlstrøm, PhD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.